ICLR News and Press, ICON plc From 05/03/22

ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the BofA Securities 2022 Healthcare Conference on Tuesday, May 10, 2022, at 5:20pm PT. Any changes to ...

IQVIA has the potential to outperform the market in a higher inflation environment. Significant growth potential with projected 17.72% FCF and 11.68% EBIT CAGR over the next 5 years. Decentralized clinical trials, the emergence of virtual trials, blockchain technologies, AI and ML...

The following slide deck was published by ICON Public Limited Company in conjunction with their 2022 Q1 earnings call. For further details see: ICON Public Limited Company 2022 Q1 - Results - Earnings Call Presentation

BBH’s price multiples indicate an undervaluation and its major holdings have started recording significant price growth. BBH has strong fundamentals and has performed well enough in the medium and long term. BBH will face some minor ups and downs since most stocks are yet t...

ICON Public Limited Company (ICLR) Q1 2022 Earnings Conference Call April 28, 2022, 8:00 AM ET Company Participants Steve Cutler – Chief Executive Officer Brendan Brennan – Chief Financial Officer Kate Haven – Vice President Investor Relations Conference Call Participants...

Icon press release (NASDAQ:ICLR): Q1 Non-GAAP EPS of $2.76 beats by $0.07. Revenue of $1.9B (+121.4% Y/Y) beats by $10M. Record net business wins in the quarter of $2,426 million; a net book to bill of 1.28. Closing backlog of $19.6 billion, an increase of 2.7% on Q4 2021 or an increase of 9....

Highlights Record net business wins in the quarter of $2,426 million; a net book to bill of 1.28. Closing backlog of $19.6 billion, an increase of 2.7% on Q4 2021 or an increase of 9.8% year over year on a Combined Company basis. Quarter 1 revenue of $1,902 mil...

Icon (NASDAQ:ICLR) is scheduled to announce Q1 earnings results on Thursday, April 28th, before market open. The consensus EPS Estimate is $2.69 (+30.6% Y/Y) and the consensus Revenue Estimate is $1.89B (+120.2% Y/Y). Over the last 2 years, ICLR has beaten EPS estimates 63% of the time and ha...

ABG,ABMD,AEP,AIT,ALNY,AOS,ARES,ASPN,ASPS,ASX,OTCPK:ATGFF,BAX,BC,BCS,BFH,BTU,CARR,CAT,OTCPK:CDUAF,CFR,CG,CHD,CMCSA,CNX,CRS,CVAC,CWT,CX,CYBE,DPZ,DTE,EME,ERJ,FAF,FBP,FCN,FCNCA,FLWS,OTCQB:FMCC,FTV,GLOP,GLYC,GOL,GTX,GVA,GWW,HSY,HUN,HZO,ICLR,IP,IPG,IRM,JKS,KBR,KDP,KEX,KIM,LAZ,LECO,LH,LIN,LKQ,LLNW,L...

The shares of the Medpace Holdings (NASDAQ:MEDP) have reached a 52-week low on Tuesday after the contract research organization set the 2022 outlook unchanged despite its 1Q 2022 financials that stood above Street forecasts. The peers in the subsector, including ICON (ICLR), IQVIA Holdin...